TIFF Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TIFF Advisory Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-86,000	Closed	-$8.62M	–	27
2025 Q3	$8.62M	Buy	+86,000	New	+$7.75M	1.79%	10
2017 Q4	–	Sell	-12,750	Closed	-$1.1M	–	10
2017 Q3	$1.1M	Buy	+12,750	New	+$1.02M	0.69%	6

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

TIFF Advisory Services's XBI Position: Q4 2025 in Review

TIFF Advisory Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 86,000 shares — an estimated $8.62M sold.

TIFF Advisory Services first reported a position in XBI in Q3 2017 and held it in 2 quarters. The position peaked at $8.62M in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

TIFF Advisory Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
TIFF Advisory Services sold 86,000 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $8.62M.
TIFF Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 2 quarters.
TIFF Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $8.62M in Q3 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on TIFF Advisory Services's 13F filing for Q4 2025, filed 9 Feb 2026.